Global Bio-chem Technology Group Company Limited (HKG:0809)
0.0570
0.00 (0.00%)
Jun 17, 2026, 2:26 PM HKT
HKG:0809 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 156.3 | 769.6 | 4,225 | -1,443 | -400.8 |
Depreciation & Amortization | 113.64 | 228.51 | 305.17 | 330.51 | 402.51 |
Other Amortization | - | - | - | - | -27.31 |
Loss (Gain) From Sale of Assets | -14.2 | -1,962 | -1,043 | 5.9 | 0.38 |
Asset Writedown & Restructuring Costs | 68.31 | 776.12 | 13.87 | 4.72 | 36.46 |
Loss (Gain) From Sale of Investments | 7.55 | -14.1 | - | - | - |
Loss (Gain) on Equity Investments | - | - | - | - | 2 |
Provision & Write-off of Bad Debts | -2.21 | -21.42 | -0.21 | -1.28 | -0.41 |
Other Operating Activities | -343.62 | 245.74 | -4,320 | 750.13 | -526.16 |
Change in Accounts Receivable | 0.8 | -7.88 | -151 | 47.03 | 25.94 |
Change in Inventory | 134.13 | -38.68 | 25.35 | -142.13 | 36.07 |
Change in Accounts Payable | 491.47 | 404.65 | 21.55 | 114.11 | -216.28 |
Change in Other Net Operating Assets | -619.53 | -304.38 | 395.95 | 394.9 | 192.39 |
Operating Cash Flow | -7.35 | 76.04 | -50.46 | -88.01 | -475.21 |
Capital Expenditures | -21.04 | - | -43.78 | -6.18 | -25.81 |
Sale of Property, Plant & Equipment | - | - | - | 5.76 | 418.4 |
Divestitures | - | -0.54 | -0.12 | - | - |
Other Investing Activities | - | - | 29.53 | - | - |
Investing Cash Flow | -21.04 | -0.54 | -14.37 | -0.41 | 392.59 |
Short-Term Debt Issued | - | - | - | - | 416.95 |
Long-Term Debt Issued | 579.33 | 13.88 | 480.96 | 192.67 | - |
Total Debt Issued | 579.33 | 13.88 | 480.96 | 192.67 | 416.95 |
Short-Term Debt Repaid | - | - | - | - | -404.27 |
Long-Term Debt Repaid | -500.54 | -1,743 | -315.15 | -70.86 | -3.37 |
Total Debt Repaid | -500.54 | -1,743 | -315.15 | -70.86 | -407.64 |
Net Debt Issued (Repaid) | 78.8 | -1,729 | 165.81 | 121.81 | 9.31 |
Issuance of Common Stock | - | 1,727 | - | - | - |
Repurchase of Common Stock | -1.22 | -2.58 | - | - | - |
Other Financing Activities | -44.01 | -71.07 | -53.19 | -12.06 | -57.97 |
Financing Cash Flow | 33.57 | -76.06 | 112.62 | 109.75 | -48.66 |
Foreign Exchange Rate Adjustments | 3.8 | -2.22 | -1.31 | -1.37 | -0.24 |
Net Cash Flow | 8.97 | -2.78 | 46.48 | 19.96 | -131.51 |
Free Cash Flow | -28.39 | 76.04 | -94.24 | -94.19 | -501.02 |
Free Cash Flow Margin | -1.25% | 3.80% | -6.86% | -740.98% | -67.11% |
Free Cash Flow Per Share | -0.00 | 0.00 | -0.01 | -0.01 | -0.06 |
Cash Interest Paid | 44.01 | 71.07 | 53.19 | 12.06 | 57.97 |
Levered Free Cash Flow | -19.51 | -2,134 | -1,495 | 62.34 | -121.68 |
Unlevered Free Cash Flow | 173.06 | -1,932 | -1,026 | 490.58 | 398.12 |
Change in Working Capital | 6.88 | 53.71 | 291.85 | 413.91 | 38.11 |